The Influence of Intravitreal Ranibizumab on Inflammation-associated Cytokine Concentrations in Eyes With Diabetic Macular Edema | Zendy

Shueh Wen Lim | Zendy; Esther BandalaSanchez | Zendy; Maria Kolic | Zendy; Sophie Rogers | Zendy; Annie K. McAuley | Zendy; Lyndell L. Lim | Zendy; Sanjeewa Wickremasinghe | Zendy

Open Access

The Influence of Intravitreal Ranibizumab on Inflammation-associated Cytokine Concentrations in Eyes With Diabetic Macular Edema

Author(s) -

Shueh Wen Lim,

Esther BandalaSanchez,

Maria Kolic,

Sophie Rogers,

Annie K. McAuley,

Lyndell L. Lim,

Sanjeewa Wickremasinghe

Publication year - 2018

Publication title -

investigative ophthalmology and visual science

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.935

H-Index - 218

eISSN - 1552-5783

pISSN - 0146-0404

DOI - 10.1167/iovs.17-23325

Subject(s) - ranibizumab , medicine , ophthalmology , diabetic macular edema , diabetic retinopathy , visual acuity , cytokine , vegf receptors , macular edema , surgery , bevacizumab , diabetes mellitus , chemotherapy , endocrinology

To evaluate the effect of intravitreal ranibizumab injections on aqueous concentrations of angiogenic or inflammatory cytokines in patients with diabetic macular edema (DME).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research